Veralto Corp (VLTO)
Instruments For Meas & Testing of Electricity & Elec Signals · Healthcare · $20.6B
Intrinsic Value (Consensus)
$60.11
Current Price
$83.98
Margin of Safety
-28.4%
28.4% Above Intrinsic Value
Value: $60
Price: $84
Valuation Model Estimates
Current Price: $83.98
DCF (Discounted Cash Flow)
$112.81
Graham Number
$32.70
Earnings Power Value
$36.50
Relative Value (P/E)
$75.20
Dividend Discount Model
$43.33
Consensus Value
$60.11
Model Assumptions
Discount Rate
10.3%
Growth Rate
12.6%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
B
69
Profitability
25/25
Strength
19/25
Valuation
9/25
Growth
16/25
Financial Health Signals
Strong profitability — ROE of 30% (above 20% is excellent)
Key Financials
- EPS (TTM)
- $3.76
- EPS (Forward)
- $4.23
- Book Value
- $12.64
- P/E Ratio
- 20.0
- Forward P/E
- 17.8
- PEG Ratio
- —
- ROE
- 30.3%
- Debt/Equity
- 86%
- Revenue Growth
- 6.0%
- Earnings Growth
- 12.6%
- Dividend Yield
- 0.2%
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance